Five Chinese probiotics powder makers target global nutrition demand

Five China-based probiotics powder manufacturers are positioning themselves for rising global demand with strain libraries, encapsulation technology, OEM/ODM services and specialized animal-nutrition offerings. The article says buyers are prioritizing production scale, regulatory certifications and customized formulations as the probiotics market heads toward strong growth through 2026 and beyond.

Why it matters: - The global probiotics market was valued at USD 72.1 billion in 2024 and is projected to reach USD 165.1 billion by 2034, according to Global Market Insights. - The global probiotic dietary supplements market alone is forecast to reach USD 10.60 billion in 2026 and grow at a 9.5% CAGR through 2031, according to MarketsandMarkets. - Chinese manufacturers are building proprietary strains, advanced encapsulation systems and international certifications to compete for global buyers. - Buyers sourcing probiotics powder are being pushed to weigh strain diversity, manufacturing scale, microencapsulation performance and regulatory compliance.

What happened: - A China-focused roundup identified five probiotics powder manufacturers serving health nutrition, private-label and animal-nutrition markets. - Shanghai Unibio Lab Co., Ltd. was presented as an academic-backed CDMO operating under the Helplifes brand. - BioGrowing Co., Ltd. was highlighted for Bifidobacterium strain development. - Jiangsu Biodep Biotechnology Co., Ltd. was described as a multi-strain formula specialist. - Wecare Probiotics Co., Ltd. was cited for high-CFU powder products. - Wuhan Healthdream Biological Technology Co., Ltd. was listed for livestock, pet and aquaculture probiotics.

The details: - Shanghai Unibio Lab was established in 2021 and is built on more than 40 years of probiotic research from Jiangnan University. - Shanghai Unibio Lab manages a proprietary strain bank of more than 30,000 microbial strains. - The strain bank includes 25,300 primary 16S rRNA strains, 13,720 draft-genome strains and 8,046 full-genome strains. - The strains were isolated from longevity elder gut, infant feces, breast milk and traditional fermented food. - Shanghai Unibio Lab says its VPro® 5-layer microencapsulation technology protects probiotics from acid, bile, oxygen and freezing damage. - The company says the technology raises freeze-drying survival by 40%, extends shelf life to 24 months and supports lyophilized powder concentrations up to 8.0×10¹¹ CFU/g. - Shanghai Unibio Lab operates four self-owned manufacturing bases with a total plant area of more than 300,000 square meters. - The company says annual output reaches 1,800 tons of probiotic raw powder and postbiotics. - Notable strains listed by Shanghai Unibio Lab include Akkermansia muciniphila AH39, Bifidobacterium breve CCFM1025 and Lactobacillus rhamnosus GG. - The AH39 strain has a US self-affirmed GRAS status and an independent sGRAS conclusion for US market clearance. - Shanghai Unibio Lab holds ISO 22000, FSSC 22000, GMP, HALAL and Kosher certifications. - BioGrowing focuses on Bifidobacterium lactis and Bifidobacterium longum for infant formula and adult gut health products. - BioGrowing emphasizes clinical research, stable supply and customized strain ratios for private-label projects. - Jiangsu Biodep specializes in multi-strain compound probiotic powders for digestive, immune and metabolic health. - Jiangsu Biodep covers raw powder production as well as finished sachet and capsule packing. - Wecare Probiotics offers certain strains with viable counts exceeding 500 billion CFU per gram. - Wecare Probiotics provides OEM/ODM services and has a distribution network in Southeast Asia and the Middle East. - Wuhan Healthdream focuses on livestock farming, pet probiotics and aquaculture. - Wuhan Healthdream’s portfolio includes heat-resistant spore-forming strains designed for feed pelleting processes.

Between the lines: - The roundup shows a market split between human-health probiotics and animal-nutrition applications. - Shanghai Unibio Lab is positioning itself around research depth and regulatory readiness, not just volume. - High-CFU claims, multi-strain blends and packaging capability remain key selling points for international supplement brands. - The emphasis on certifications and market-clearance claims reflects the importance of export readiness in probiotics sourcing.

What's next: - Manufacturers are likely to keep investing in strain discovery, encapsulation technology and compliance credentials as demand expands. - Buyers will keep comparing suppliers on scale, strain specialization, customization and quality systems before placing orders. - The article signals continued competition among Chinese suppliers for private-label and contract-manufacturing business.

The bottom line: - China’s probiotics powder market is being shaped by research-backed manufacturing, specialized strain portfolios and export-oriented quality controls.